β-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects

[1]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[2]  J. Blumenfeld,et al.  Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients. , 1997, Journal of hypertension.

[3]  Bertram Pitt,et al.  Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) , 1997, The Lancet.

[4]  J. Ménard,et al.  Additive effects of losartan and enalapril on blood pressure and plasma active renin. , 1997, Hypertension.

[5]  J. Laragh,et al.  Plasma renin activity and plasma prorenin are not suppressed in hypertensives surviving to old age. , 1996, American journal of hypertension.

[6]  K. Catt,et al.  Angiotensin receptors and their antagonists. , 1996, The New England journal of medicine.

[7]  J. Laragh,et al.  Plasma and renal prorenin/renin, renin mRNA, and blood pressure in Dahl salt-sensitive and salt-resistant rats. , 1996, Hypertension.

[8]  J. Ménard,et al.  Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. , 1995, Circulation.

[9]  D. Snavely,et al.  A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. , 1995, Hypertension.

[10]  Raymond C. Schneider,et al.  ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.

[11]  J. Rouleau,et al.  Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. , 1994, Journal of the American College of Cardiology.

[12]  J. Laragh,et al.  Adrenergic regulation of renin secretion and renal hemodynamics during deliberate hypotension in humans. , 1993, The American journal of physiology.

[13]  J. Laragh,et al.  Clinical evaluation and differential diagnosis of the individual hypertensive patient. , 1991, Clinical chemistry.

[14]  J. Sealey.  Plasma renin activity and plasma prorenin assays. , 1991, Clinical chemistry.

[15]  J. Laragh,et al.  Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. , 1991, The New England journal of medicine.

[16]  P. Timmermans,et al.  Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). , 1990, The Journal of pharmacology and experimental therapeutics.

[17]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[18]  A. Rumley,et al.  Neuroendocrine activation after acute myocardial infarction. , 1988, British heart journal.

[19]  J. Laragh,et al.  Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise. , 1982, The American journal of cardiology.

[20]  J. Laragh,et al.  Interruption of the Renin‐Angiotensin System in Hypertensive Patients by Captopril Induces Sustained Reduction in Aldosterone Secretion, Potassium Retention and Natriuresis , 1979, Hypertension.

[21]  J. Laragh,et al.  Studies of plasma aldosterone in anephric people: evidence for the fundamental role of the renin system in maintaining aldosterone secretion. , 1978, The Journal of clinical endocrinology and metabolism.

[22]  J. Laragh,et al.  PLASMA RENIN AND "PRORENIN" IN ESSENTIAL HYPERTENSION DURING SODIUM DEPLETION, BETA-BLOCKADE, AND REDUCED ARTERIAL PRESSURE , 1977, The Lancet.

[23]  J. Laragh,et al.  Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. , 1977, The New England journal of medicine.

[24]  E. Enger,et al.  Effect of sodium depletion on plasma renin concentration before and during adrenergic beta-receptor blockade with propranolol in normotensive man. , 1976, The American journal of medicine.

[25]  D. Shand,et al.  Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension. , 1976, The New England journal of medicine.

[26]  H. Vetter,et al.  Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure. , 1976, The American journal of medicine.

[27]  J. Laragh,et al.  Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone. , 1973, The American journal of cardiology.

[28]  J. Laragh,et al.  Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. , 1973, The American journal of cardiology.

[29]  J. Laragh,et al.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. , 1972, The New England journal of medicine.

[30]  J. Laragh,et al.  Essential hypertension: renin and aldosterone, heart attack and stroke. , 1972, The New England journal of medicine.

[31]  A. Michelakis,et al.  The effect of chronic adrenergic receptor blockade on plasma renin activity in man. , 1972, The Journal of clinical endocrinology and metabolism.